Ra Pharmaceuticals Inc (RARX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
48.00 -0.01 (-0.02%) 04/01/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 48.00 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -102,688 | -64,943 | -54,439 | -28,864 | -13,943 |
| Depreciation Amortization | 1,619 | 1,597 | 1,524 | 1,274 | 897 |
| Other Working Capital | -972 | 729 | 555 | 3,677 | 285 |
| Other Operating Activity | 14,680 | 7,671 | 5,581 | 2,070 | 744 |
| Operating Cash Flow | $-87,361 | $-54,946 | $-46,779 | $-21,843 | $-12,017 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -865 | -1,034 | -1,412 | -5,105 | -331 |
| Other Investing Activity | 0 | 0 | 0 | 9 | 1 |
| Investing Cash Flow | $-865 | $-1,034 | $-1,412 | $-5,096 | $-330 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 5,000 |
| Common Stock Issued | 144,519 | 195,798 | 90 | 98,118 | 84 |
| Other Financing Activity | -1,123 | -377 | 670 | 27,118 | 23,944 |
| Financing Cash Flow | $143,396 | $195,421 | $760 | $125,236 | $29,028 |
| Beginning Cash Position | 211,156 | 71,715 | 119,146 | 20,849 | 4,168 |
| End Cash Position | 266,326 | 211,156 | 71,715 | 119,146 | 20,849 |
| Net Cash Flow | $55,170 | $139,441 | $-47,431 | $98,297 | $16,681 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,361 | -54,946 | -46,779 | -21,843 | -12,017 |
| Capital Expenditure | -865 | -1,034 | -1,412 | -5,105 | -331 |
| Free Cash Flow | -88,226 | -55,980 | -48,191 | -26,948 | -12,348 |